Tumor-dendritic cell fusion technology and immunotherapy strategies - PubMed (original) (raw)
Comment
. 2001 Mar-Apr;24(2):99-100.
Affiliations
- PMID: 11265778
Comment
Tumor-dendritic cell fusion technology and immunotherapy strategies
S Shu et al. J Immunother. 2001 Mar-Apr.
No abstract available
Comment on
- Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T. Akasaki Y, et al. J Immunother. 2001 Mar-Apr;24(2):106-13. J Immunother. 2001. PMID: 11265767 - A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dentritomas.
Holmes LM, Li J, Sticca RP, Wagner TE, Wei Y. Holmes LM, et al. J Immunother. 2001 Mar-Apr;24(2):122-9. J Immunother. 2001. PMID: 11265769
Similar articles
- Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J, Koido S, Calderwood SK. Gong J, et al. Expert Rev Vaccines. 2008 Sep;7(7):1055-68. doi: 10.1586/14760584.7.7.1055. Expert Rev Vaccines. 2008. PMID: 18767954 Review. - Dendritic cell-based cancer therapy.
Conrad C, Nestle FO. Conrad C, et al. Curr Opin Mol Ther. 2003 Aug;5(4):405-12. Curr Opin Mol Ther. 2003. PMID: 14513684 Review. - Immunotherapy. Fusion induces tumour rejection.
Hart I, Colaco C. Hart I, et al. Nature. 1997 Aug 14;388(6643):626-7. doi: 10.1038/41662. Nature. 1997. PMID: 9262393 No abstract available. - The therapeutic role of dendritic cells in cancer immunotherapy.
Lemoli RM, Curti A, Fogli M, Ferri E, Baccarani M. Lemoli RM, et al. Haematologica. 2002 Aug;87(8 Suppl):62-6. Haematologica. 2002. PMID: 12412393 Review. No abstract available.
Cited by
- Collagen I enhances the efficiency and anti-tumor activity of dendritic-tumor fusion cells.
He J, Zheng R, Zhang Z, Tan J, Zhou C, Zhang G, Jiang X, Sun Q, Zhou S, Zheng D, Huang Y, Wu L, Lai Z, Li J, Yang N, Lu X, Zhao Y. He J, et al. Oncoimmunology. 2017 Aug 8;6(12):e1361094. doi: 10.1080/2162402X.2017.1361094. eCollection 2017. Oncoimmunology. 2017. PMID: 29209562 Free PMC article. - Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12.
Zheng R, Cohen PA, Paustian CA, Johnson TD, Lee WT, Shu S, Koski GK. Zheng R, et al. Cancer Res. 2008 Jun 1;68(11):4045-9. doi: 10.1158/0008-5472.CAN-07-6669. Cancer Res. 2008. PMID: 18519662 Free PMC article. - Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F. Galea-Lauri J, et al. Cancer Immunol Immunother. 2004 Nov;53(11):963-77. doi: 10.1007/s00262-004-0542-8. Epub 2004 May 14. Cancer Immunol Immunother. 2004. PMID: 15146294 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources